An in vitro study elucidating the synergistic effects of aqueous cinnamon extract and an anti-TNF-α biotherapeutic: implications for a complementary and alternative therapy for non-responders

Table 6 Changes in the EC50 and corresponding p-values after the trans-cinnamaldehyde (TCA) synergy experiment in the L929 cell line

trans-cinnamaldehyde concentration	Infliximab EC50 [ng/mL]	p-values
Control	6.800	NA
40 µg/mL	3.777	< 0.0001
32 µg/mL	4.275	< 0.0001
16 µg/mL	5.471	< 0.0001
8 µg/mL	6.124	0.0099
4 µg/mL	6.625	0.5145

ISSN: 2662-7671